Novelty Nobility Inc.

Novel Science, Noble Management

General Information
Company Name
Novelty Nobility Inc.
Founded Year
2017
Location (Offices)
Korea South +2
Founders / Decision Makers
Jin Cho - Chief Finance & Business Officer Sang Gyu Park - Founder & CEO
Number of Employees
10
Industries
Biotechnology, Health Care, Health and Wellness +1
Funding Stage
Series B
Social Media

Novelty Nobility Inc. - Company Profile

Novelty Nobility Inc. is a private clinical stage biotech company located in Pangyo, South Korea, and Boston, Massachusetts. Founded in 2017, the company is focused on the research of novel angiogenesis targets and developing antibody-based therapeutics in ophthalmology and oncology. Their slogan, "Novel Science, Noble Management," embodies their commitment to innovative science and ethical management.

Recently, on 13 May 2022, the company secured a significant KRW34.10B Series B investment from a consortium of investors including KB Investments, Mirae Asset Venture Investment, HB Investment, K2 Investment Partners, BSK Investment, SGI Venture Capital, and SL Investment.

As Novelty Nobility Inc. continues to make strides in the fields of biotechnology and healthcare, its unique approach and strong investor backing position it as a promising player in the global biotech industry.

Taxonomy: Biotech, Clinical Stage, Angiogenesis Research, Antibody-Based Therapeutics, Ophthalmology, Oncology, Drug Development, Stem Cell Factor, c-KIT, Monoclonal Antibody, ADC (Antibody-Drug Conjugate)

Funding Rounds & Investors of Novelty Nobility Inc. (4)

View All
Funding Stage Amount No. Investors Investors Date
Series B KRW34.10B 7
KB Investments, investor in Novelty Nobility Inc.'s Series B round Mirae Asset Venture Investment, investor in Novelty Nobility Inc.'s Series B round HB Investment, investor in Novelty Nobility Inc.'s Series B round K2 Investment Partners, investor in Novelty Nobility Inc.'s Series B round BSK Investment, investor in Novelty Nobility Inc.'s Series B round SL Investment, investor in Novelty Nobility Inc.'s Series B round SGI Venture Capital, investor in Novelty Nobility Inc.'s Series B round
13 May 2022
Series B KRW8.00B 3
DAYLI Partners, investor in Novelty Nobility Inc.'s Series B round Dong-A ST, investor in Novelty Nobility Inc.'s Series B round
Mega Investment 		05 Mar 2021
Non Equity Assistance Unknown - 01 Jun 2020
Series A KRW10.00B - 04 Feb 2020

Latest News of Novelty Nobility Inc.

View All

No recent news or press coverage available for Novelty Nobility Inc..

Similar Companies to Novelty Nobility Inc.

View All
Araris Biotech AG - Similar company to Novelty Nobility Inc.
Araris Biotech AG Building tomorrow's antibody-drug conjugates (ADCs)
Myricx Bio - Similar company to Novelty Nobility Inc.
Myricx Bio Developing a new class of ADCs based on NMT inhibition to treat cancer
Novelogics Biotechnology Inc. - Similar company to Novelty Nobility Inc.
Novelogics Biotechnology Inc. Pre-clinical stage biotech company developing an antibody immunotherapy drug for cancer using an “Interceptor"​ approach
Immunocan - Similar company to Novelty Nobility Inc.
Immunocan A leading gene-edited animal platform for discovering fully human and alpaca antibodies.
HiFiBiO Therapeutics - Similar company to Novelty Nobility Inc.
HiFiBiO Therapeutics HiFiBiO Therapeutics is a clinical stage biotherapeutics company mobilizing the human immune system to combat disease.